CompletedPhase 4NCT03087890

Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria

Studying Pneumocystosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Bergen
Principal Investigator
Joel Manyahi, MD, MD
Muhimbili University of Health and Allied Sciences
Intervention
Cotrimoxazole(drug)
Enrollment
537 target
Eligibility
18 years · All sexes
Timeline
2017 – 2019

Study locations (6)

Collaborators

Haukeland University Hospital · Muhimbili University of Health and Allied Sciences · Helse Vest

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03087890 on ClinicalTrials.gov

Other trials for Pneumocystosis

Additional recruiting or active studies for the same condition.

See all trials for Pneumocystosis →

← Back to all trials